Work

Durvalumab gemcitabine cisplatin as neoadjuvant therapy in borderline resectable cholangiocarcinoma

Year: 2025

Type: article

Study design: Observational Study

Source: HPB

DOI: 10.1016/j.hpb.2025.03.384

Authors: Y. Dong, V. Podrascanin, J. Santol, M. Ammann, L. Kankeu Fonkoua, R. Graham, C. Conboy, N. Tran, S. Warner, R. Smoot, P. Starlinger

Institution: Mayo Clinic

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4410195806

FWCI:

Cites:

Cited by:

Related to: 10